Table 3.
Univariate and multivariate analyses associated to death risk with all significant variables.
VARIABLES | p-value | OR | OR 95% CI | AUC | AUC 95% CI | p-value | OR | OR 95% CI |
---|---|---|---|---|---|---|---|---|
Lymphocytes | 0.018 | 0.2 | 0.05–0.076 | 0.77 | 0.634–0.873 | 0.027 | 0.15 | 0.02–0.81 |
% Th1 | 0.514 | 0.65 | 0.18–2.33 | 0.55 | 0.413–0.687 | – | – | – |
%Th17 | 0.085 | 3.8 | 0.83–17.37 | 0.63 | 0.495–0.761 | – | – | – |
% Th2 | 0.777 | 0.86 | 0.31–2.38 | 0.52 | 0.385–0.661 | – | – | – |
%Th1 PD-1-/ICOS− | 0.067 | 0.28 | 0.07–10.9 | 0.68 | 0.545–0.803 | – | – | – |
%Th17 PD-1-/ICOS− | 0.257 | 2.38 | 0.53–10.69 | 0.6 | 0.464–0.734 | – | – | – |
%Th2 PD-1-/ICOS− | 0.259 | 27.778 | 0.47–16.35 | 0.618 | 0.451–0.766 | – | – | – |
% Th1 PD-1-/ICOS+ | 0.710 | 0.72 | 0.13–3.96 | 0.53 | 0.391–0.666 | – | – | – |
%Th17 PD-1-/ICOS+ | 0.574 | 1.53 | 0.34–6.31 | 0.55 | 0.411–0.685 | – | – | – |
%Th2 PD-1-/ICOS+ | 0.161 | 2.57 | 0.68–9.69 | 0.58 | 0.429–0.712 | – | – | – |
%Th1 PD-1+/ICOS+ | 0.631 | 1.79 | 0.14–19.46 | 0.52 | 0.384–0.659 | – | – | – |
%Th17 PD-1+/ICOS+ | 0.238 | 5.6 | 0.31–99.41 | 0.54 | 0.405–0.68 | – | – | – |
%Th2 PD-1+/ICOS + | 0.09 | 0.24 | 0.04–1.28 | 0.66 | 0.52–0.783 | – | – | – |
%Th1 PD-1+/ICOS− | 0.750 | 0.69 | 0.07–6.47 | 0.52 | 0.382–0.657 | – | – | – |
%Th17 PD-1+/ICOS− | 0.073 | 3.86 | 0.87–16.97 | 0.656 | 0.514–0.780 | – | – | – |
%Th2 PD-1+/ICOS− | 0.021 | 7.23 | 1.33–39.12 | 0.72 | 0.589–0.837 | 0.027 | 13.88 | 1.33–143.88 |
Area Under the Curve | 0.879 | 0.760–952 |
PD-1-/ICOS−, Quiescent; PD-1-/ICOS+, early-activated; PD-1+/ICOS+, late-activated; PD-1+/ICOS, senescent.